Cellular Dynamics Signs Agreement with Nestlé Institute of Health Sciences
News Jan 08, 2014
Cellular Dynamics International announced the signing of a long-term supply agreement with the Nestlé Institute of Health Sciences SA (NIHS).Terms of the agreement were not disclosed.
CDI’s iCell® product line includes cardiomyocytes, neurons, hepatocytes, and endothelial cells, with numerous other cell types in development. The company’s MyCell® Products are cell products manufactured from donor samples using iPSC technology to make stem cells or differentiated cells from any individual, including those with diseases of interest.
“The ongoing work and this long-term supply agreement with NIHS demonstrate the utility and broad applicability of our iCell and MyCell Products,” said Bob Palay, chief executive officer of CDI. “Our customers already benefit from a reliable supply of human iPSCs and human differentiated cells for their biomedical research and drug discovery. This supply agreement with NIHS adds nutritional research as yet another field that will benefit from CDI’s products and expertise.”
The EU's policy on genetically modified organisms (GMO's) is extremely strict and prevents new GMO crops from being authorized. The policy is based on arguments about the risk and unnaturalness of GMO plants - but these arguments cannot justify the restrictive regulation, three researchers conclude in a new study.READ MORE